|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,983.00 GBX | -0.03% |
|
+2.99% | +8.69% |
| 25/06 | Cooler PCE, Hotter Chips |  |
| 25/06 | Bernstein: GSK Poised for Sustainable Growth Amid 'Much More Durable' HIV Franchise; Price Target, Forecasts Up | MT |
| Market Cap | 79.02B 104B 91.56B 84.4B 148B 9,851B 151B 1,014B 393B 4,869B 392B 384B 16,882B | P/E 2026 * |
12.6x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 93.27B 123B 108B 99.62B 175B 11,628B 179B 1,197B 463B 5,747B 463B 453B 19,927B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.29% | Yield 2026 * |
3.53% | Yield 2027 * | 3.7% |
Last Transcript: GSK plc
| 1 day | -0.03% | ||
| 1 week | +2.99% | ||
| Current month | +5.39% | ||
| 1 month | +3.01% | ||
| 3 months | -3.13% | ||
| 6 months | +9.83% | ||
| Current year | +8.69% |
| 1 week | 1,911 |  | 1,996.5 |
| 1 month | 1,805 | | 2,191 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/06 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 08/06 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 22/05 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +2.99% | +42.15% | +39.67% | 104B | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,006B | |
| +3.99% | +11.50% | +67.53% | +55.63% | 589B | |
| +4.20% | +17.03% | +35.63% | +87.74% | 430B | |
| +0.99% | +4.85% | +27.93% | +22.82% | 331B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | |
| +1.56% | +6.14% | +28.38% | +59.45% | 190B | |
| +3.26% | +3.33% | +18.83% | +67.03% | 154B | |
| Average | +1.86% | +7.92% | +31.88% | +52.71% | 359.02B | |
| Weighted average by Cap. | +2.18% | +8.96% | +40.26% | +78.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.8B 44.67B 39.16B 36.1B 63.37B 4,213B 64.69B 434B 168B 2,082B 168B 164B 7,221B | 35.5B 46.91B 41.13B 37.91B 66.56B 4,425B 67.94B 456B 176B 2,187B 176B 172B 7,584B |
| Net income | 6.48B 8.57B 7.51B 6.92B 12.16B 808B 12.41B 83.23B 32.21B 399B 32.17B 31.47B 1,385B | 7.02B 9.28B 8.14B 7.5B 13.17B 876B 13.44B 90.17B 34.89B 433B 34.86B 34.09B 1,501B |
| Net Debt | 14.25B 18.84B 16.52B 15.22B 26.72B 1,777B 27.28B 183B 70.8B 878B 70.73B 69.18B 3,045B | 11.19B 14.79B 12.97B 11.95B 20.98B 1,395B 21.42B 144B 55.58B 689B 55.53B 54.32B 2,391B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | GBX 1,983.00 | -0.03% | 13,838,097 |
| 25/06/26 | GBX 1,983.50 | +1.72% | 8,999,812 |
| 24/06/26 | GBX 1,950.00 | -0.38% | 5,924,447 |
| 23/06/26 | GBX 1,957.50 | +1.71% | 8,306,059 |
| 22/06/26 | GBX 1,924.50 | -0.05% | 3,567,970 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
